Valuation : Revvity, Inc.

Market Cap 14.37B 74.85B 12.38B 11.61B 10.6B 19.97B 1,374B 20.03B 138B 53.75B 693B 53.96B 52.79B 2,299B P/E 2026 *
48.7x
P/E 2027 * 37.8x
Enterprise Value 16.34B 85.09B 14.08B 13.2B 12.05B 22.7B 1,561B 22.77B 157B 61.1B 788B 61.34B 60B 2,613B EV / Sales 2026 *
5.73x
EV / Sales 2027 * 5.24x
Free-Float
99.73%
Yield 2026 *
0.23%
Yield 2027 * 0.21%
1 day+3.00%
Current month+3.00%
1 month+3.00%
3 months+12.88%
6 months+7.63%
Current year+10.16%
1 month 20.6
Extreme 20.6
20.6
Current year 14.91
Extreme 14.91
22.24
1 year 14.91
Extreme 14.91
22.24
3 years 14.51
Extreme 14.51
26.28
5 years 14.51
Extreme 14.51
39.55
10 years 11.96
Extreme 11.957142
39.55
Manager TitleAgeSince
Chief Executive Officer 61 2019-12-29
Director of Finance/CFO 37 2022-09-05
Chief Tech/Sci/R&D Officer - 2023-04-30
Director TitleAgeSince
Chairman 68 2019-12-29
Director/Board Member 74 2012-02-06
Director/Board Member 72 2016-07-26
Change 5-day change 1-year change 3-year change Capi.($)
+3.00%0.00% - - 14.37B
-1.35%-1.13%+26.27%+11.30% 230B
+0.18%-1.27%+4.98%-18.21% 152B
+1.51%-1.64%-21.28%+16.96% 132B
+0.36%-7.01%-55.60%-13.69% 67.88B
+0.29%+0.47%+10.90%+15.92% 52B
+0.66%-1.69%-16.47%-13.96% 51.05B
-2.44%-3.25%+22.43%+25.40% 43.38B
-1.56%+0.97%+37.41%+44.40% 40.74B
+1.94%+3.81%-12.45%+46.38% 34.67B
Average +0.26%-1.19%-0.42%+12.72% 89.25B
Weighted average by Cap. -0.09%-1.46%+2.51%+7.18%

Financials

2026 *2027 *
Net sales 2.85B 14.85B 2.46B 2.3B 2.1B 3.96B 272B 3.97B 27.33B 10.66B 138B 10.7B 10.47B 456B 3B 15.65B 2.59B 2.43B 2.22B 4.17B 287B 4.19B 28.8B 11.24B 145B 11.28B 11.03B 481B
Net income 283M 1.47B 244M 229M 209M 393M 27.06B 395M 2.71B 1.06B 13.66B 1.06B 1.04B 45.29B 355M 1.85B 306M 287M 262M 494M 33.96B 495M 3.41B 1.33B 17.14B 1.33B 1.31B 56.84B
Net Debt 1.96B 10.23B 1.69B 1.59B 1.45B 2.73B 188B 2.74B 18.83B 7.35B 94.79B 7.38B 7.22B 314B 1.37B 7.14B 1.18B 1.11B 1.01B 1.9B 131B 1.91B 13.13B 5.12B 66.1B 5.14B 5.03B 219B
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
128.80USD
Average target price
121.07USD
Spread / Average Target
-6.00%

Quarterly revenue - Rate of surprise